Universe Pharmaceuticals Inc (UPC)
2.923
+0.25
(+9.48%)
USD |
NASDAQ |
May 31, 16:00
2.71
-0.21
(-7.29%)
After-Hours: 20:00
Universe Pharmaceuticals Enterprise Value: -2.364M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -2.364M |
| May 30, 2024 | -3.287M |
| May 29, 2024 | -2.886M |
| May 28, 2024 | -2.995M |
| May 24, 2024 | -4.271M |
| May 23, 2024 | -3.907M |
| May 22, 2024 | -3.943M |
| May 21, 2024 | -3.724M |
| May 20, 2024 | -4.527M |
| May 17, 2024 | -3.579M |
| May 16, 2024 | -3.870M |
| May 15, 2024 | -3.615M |
| May 14, 2024 | -3.451M |
| May 13, 2024 | -4.508M |
| May 10, 2024 | -5.11M |
| May 09, 2024 | -5.183M |
| May 08, 2024 | -4.454M |
| May 07, 2024 | -4.563M |
| May 06, 2024 | -5.074M |
| May 03, 2024 | -5.183M |
| May 02, 2024 | -5.11M |
| May 01, 2024 | -4.782M |
| April 30, 2024 | -4.235M |
| April 29, 2024 | -4.308M |
| April 26, 2024 | -5.074M |
| Date | Value |
|---|---|
| April 25, 2024 | -4.600M |
| April 24, 2024 | -5.204M |
| April 23, 2024 | -5.001M |
| April 22, 2024 | -5.912M |
| April 19, 2024 | -5.475M |
| April 18, 2024 | -5.037M |
| April 17, 2024 | -5.620M |
| April 16, 2024 | -6.204M |
| April 15, 2024 | -5.256M |
| April 12, 2024 | -6.751M |
| April 11, 2024 | -6.933M |
| April 10, 2024 | -6.641M |
| April 09, 2024 | -6.459M |
| April 08, 2024 | -6.459M |
| April 05, 2024 | -5.219M |
| April 04, 2024 | -4.782M |
| April 03, 2024 | -2.995M |
| April 02, 2024 | -3.907M |
| April 01, 2024 | -5.037M |
| March 28, 2024 | -5.037M |
| March 27, 2024 | -5.985M |
| March 26, 2024 | -6.422M |
| March 25, 2024 | -6.860M |
| March 22, 2024 | -5.803M |
| March 21, 2024 | -5.475M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-18.89M
Minimum
Sep 28 2023
110.40M
Maximum
Mar 29 2021
6.015M
Average
-1.802M
Median
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 50.79M |
| Zai Lab Ltd | 1.153B |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | 35.64M |
Enterprise Value Related Metrics
| Earnings Yield | -58.16% |
| Normalized Earnings Yield | -61.54 |